CYTSA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.450600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.644600E-01
Normal-vs-Stage2
2.654600E-01
Normal-vs-Stage3
4.774300E-02
Normal-vs-Stage4
5.867400E-01
Stage1-vs-Stage2
2.038600E-01
Stage1-vs-Stage3
6.644100E-02
Stage1-vs-Stage4
6.108600E-01
Stage2-vs-Stage3
1.897170E-01
Stage2-vs-Stage4
7.852200E-01
Stage3-vs-Stage4
3.155800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.550600E-01
Normal-vs-AfricanAmerican
8.110800E-01
Normal-vs-Asian
8.672400E-02
Caucasian-vs-AfricanAmerican
3.605200E-01
Caucasian-vs-Asian
1.810640E-01
AfricanAmerican-vs-Asian
8.766300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.145600E-01
Normal-vs-Female
4.026800E-01
Male-vs-Female
3.921800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.445600E-01
Normal-vs-Age(41-60Yrs)
6.286800E-01
Normal-vs-Age(61-80Yrs)
2.873400E-01
Normal-vs-Age(81-100Yrs)
5.151900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.772000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.906000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.491800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.791600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.338410E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.241600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.092640E-01
Normal-vs-Daily Drinker
3.533900E-02
Normal-vs-Weekly Drinker
4.879400E-01
Normal-vs-Occasional Drinker
4.974200E-01
Normal-vs-Social Drinker
7.790200E-01
Non Drinker-vs-Daily Drinker
6.751600E-01
Non Drinker-vs-Weekly Drinker
2.248400E-01
Non Drinker-vs-Occasional Drinker
1.412560E-01
Non Drinker-vs-Social Drinker
3.273800E-02
Daily Drinker-vs-Weekly Drinker
1.199840E-01
Daily Drinker-vs-Occasional Drinker
6.858300E-02
Daily Drinker-vs-Social Drinker
1.367990E-02
Weekly Drinker-vs-Occasional Drinker
9.145600E-01
Weekly Drinker-vs-Social Drinker
4.878200E-01
Occasional Drinker-vs-Social Drinker
5.146000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.330600E-01
Normal-vs-Grade 2
9.096400E-01
Normal-vs-Grade 3
8.973400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.197200E-01
Grade 1-vs-Grade 3
5.946600E-01
Grade 1-vs-Grade 4
9.330600E-01
Grade 2-vs-Grade 3
7.636800E-01
Grade 2-vs-Grade 4
9.096400E-01
Grade 3-vs-Grade 4
8.973400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.613240E-01
Normal-vs-NonDiabetic
3.004200E-01
Diabetic-vs-NonDiabetic
4.356600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.155410E-01
Normal-vs-NoPancreatitis
2.985400E-01
Pancreatitis-vs-NoPancreatitis
8.279600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.691800E-01
Normal-vs-N1
2.951000E-01
N0-vs-N1
7.270200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.838830E-01
Normal-vs-TP53-NonMutant
7.665800E-01
TP53-Mutant-vs-TP53-NonMutant
5.781500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
